Tlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosis
Open Access
- 18 May 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Abstract
Toll-like receptor 9 (TLR9) recognizes bacterial, viral and self DNA and play an important role in immunity and inflammation. However, the role of TLR9 in obesity is less well-studied. Here, we generate B-cell-specific Tlr9-deficient (Tlr9fl/fl/Cd19Cre+/-, KO) B6 mice and model obesity using a high-fat diet. Compared with control mice, B-cell-specific-Tlr9-deficient mice exhibited increased fat tissue inflammation, weight gain, and impaired glucose and insulin tolerance. Furthermore, the frequencies of IL-10-producing-B cells and marginal zone B cells were reduced, and those of follicular and germinal center B cells were increased. This was associated with increased frequencies of IFNγ-producing-T cells and increased follicular helper cells. In addition, gut microbiota from the KO mice induced a pro-inflammatory state leading to immunological and metabolic dysregulation when transferred to germ-free mice. Using 16 S rRNA gene sequencing, we identify altered gut microbial communities including reduced Lachnospiraceae, which may play a role in altered metabolism in KO mice. We identify an important network involving Tlr9, Irf4 and Il-10 interconnecting metabolic homeostasis, with the function of B and T cells, and gut microbiota in obesity.Keywords
Funding Information
- Diabetes Action Research and Education Foundation (HD097808)
This publication has 101 references indexed in Scilit:
- IRF4: Immunity. Malignancy! Therapy?Clinical Cancer Research, 2009
- Interferon regulatory factor 4 and 8 in B-cell developmentTrends in Immunology, 2008
- Metabolic Endotoxemia Initiates Obesity and Insulin ResistanceDiabetes, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Effector and regulatory events during natural killer–dendritic cell interactionsImmunological Reviews, 2006
- Modifying Toll-like Receptor 9 Signaling for Therapeutic UseMini-Reviews in Medicinal Chemistry, 2006
- Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells☆Gastroenterology, 2004
- IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte developmentGenes & Development, 2003
- IL-10, an inflammatory/inhibitory cytokine, but not alwaysImmunology Letters, 2003
- A Toll-like receptor recognizes bacterial DNANature, 2000